Batch: GF-BPC10-B241 Key analytical results include: Assay Content: 10.71 mg Identification Retention Time: 0.998 Identification Spectrum: 996 Purity: greater than 99.8 percent Bacterial Endotoxins: 0.0120 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
Linciano P, Sorbi C, Rossino G, Rossi D, Marsala A, Denora N, et al
Is there an age limit for those who qualify for Vitamin B12 injections
Body composition changes typically become visible at 8 to 12 weeks
